The complete secondary prevention framework — every medication with evidence level, lifestyle targets with outcome data, cardiac rehab (the 26% mortality reduction explained), and the emotional dimension of recovery most patients navigate alone.
Surviving a heart attack or major cardiac event is the beginning of the most critical phase of cardiac care — not the end. The evidence for secondary prevention is among the most rigorous in all of medicine. Every intervention in this guide has randomized controlled trial evidence. The patients who survive long-term are the ones who take all of it seriously.
This guide provides the complete secondary prevention checklist Dr. Nyange uses with every post-cardiac patient, including the evidence levels, the medication duration guidance, and the cardiac rehab data that most patients never see.
Aspirin, DAPT, high-intensity statin, beta-blocker, ACE/ARNi, SGLT2i, ezetimibe/PCSK9i — evidence level and duration for each.
Why stopping your antiplatelet drug early — even for a dental procedure — can trigger stent thrombosis.
10 targets with specific outcome data: LDL <70, BP <130/80, cardiac rehab, Mediterranean diet, smoking, depression.
26% CV mortality reduction, 18% hospitalization reduction — and why only 20-30% of eligible patients attend.
Post-MI depression doubles 1-year mortality — it is a cardiac risk factor, not a character weakness, and it is treatable.
Why empagliflozin and dapagliflozin are now recommended post-MI regardless of diabetes status.
“A cardiac event is both a warning and an opportunity. The warning is that your coronary arteries need aggressive management. The opportunity is that most patients who commit fully to secondary prevention — every medication, cardiac rehab, the lifestyle changes — do dramatically better than those who do half.”
Every intervention in this guide has Level A evidence. All of it matters.
Get Secondary Prevention Guide — $37